Predict your next investment

HEALTHCARE | Biotechnology
aspenbiopharma.com

See what CB Insights has to offer

Founded Year

2000

Stage

PIPE - II | IPO

Total Raised

$2.53M

About AspenBio Pharma

AspenBio Pharma is a Healthcare/Biotechnology company based in Castle Rock, Colorado. AspenBio Pharma's investors include Joshua Tree Asset Management, HealthCor Management, Corriente Advisors, Iroquois Capital and Ardsley Partners.

AspenBio Pharma Headquarter Location

1585 South Perry Street

Castle Rock, Colorado, 80104,

United States

303-794-2000

Latest AspenBio Pharma News

Venaxis Inc. formerly AspenBio Pharma Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Nov 29, 2016

Advertisement Topics   Track topics on Twitter Track topics that are important to you Printed From BioPortfolio.com Venaxis, Inc. formerly AspenBio Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 07:24 EST 29 Nov 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » Venaxis, Inc. formerly AspenBio Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Venaxis, Inc. formerly AspenBio Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Venaxis, Inc. formerly AspenBio Pharma, Inc. since January 2007. Key Findings Provides intelligence on Venaxis, Inc. formerly AspenBio Pharma, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Venaxis, Inc. formerly AspenBio Pharma, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Venaxis, Inc. formerly AspenBio Pharma, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Venaxis, Inc. formerly AspenBio Pharma, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

AspenBio Pharma Patents

AspenBio Pharma has filed 8 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/4/2004

10/23/2018

Progestogens, Human female endocrine system, Fertility medicine, Cattle breeds, G protein coupled receptors

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/4/2004

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/23/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Progestogens, Human female endocrine system, Fertility medicine, Cattle breeds, G protein coupled receptors

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.